Year
Edition number
№10 / 2025
ORIGINAL STUDIES
Balykova L.A., Yamashkina E.I., Stolyarova V.V., Esina M.V., Kunyaeva T.A., Prekina V.I., Samoshkina E.S., Ledyajkina L.V.
Correction of cardiovascular risk factors and metabolic health indexes in patients with type 2 diabetes mellitus during semaglutide therapy7-14
Berezenko I.L., Filippov E.V., Volchenkova M.V., Nikiforov A.A.
Estimation of fibrosis markers’ level in individuals with different obesity phenotypes16-22
Bushmanov P.A., Filippov E.V., Sinyaeva A.S., Shelomentsev V.V., Nekrasova M.S., Cherdantseva T.M.
Diagnosis of myocardial fibrosis in arterial hypertension: An experimental study24-29
Fomicheva M.L., Zakharova M.A., Evdakov V.A.
To the aspect of diabetes mellitus prevention program among the population of the Novosibirsk Region30-37
Gerasimenko O.N., Zhamalov L.M., Nikolaev K.Yu., Zimina Yu.D., Tolmacheva A.A.
Prevention of progression of chronic heart failure with preserved ejection fraction: Estimation of the correlation between NT-proBNP levels and clinical and functional characteristics during control of the disease38-46
Chelnokova O.G.
Efficacy of the use of phytotherapy – thyme and ivy liquid extract – in rehabilitation after coronavirus infection48-55
Shramko V.S., Kashtanova E.V., Shcherbakova L.V., Simonova G.I., Afanasieva A.D., Ragino Yu.I.
Study of unsaturated fatty acids profile in male individuals with obesity, including abdominal obesity, from Novosibirsk region56-64
Lebedeva N.N., Maximov M.L., Malinnikova E.Yu.
Clinical experience of using umifenovir for ARVI prevention during its seasonal increase in patients with secondary immunodeficiency conditions66-72
Abukova A.Kh, Almova I.Kh., Umetov M.A., Bitsuev T.M., Khamizov T.Kh., Farah A.M., Suleiman M.H.M.
Efficacy of antioxidant therapy in reducing visceral obesity among overweight individuals73-81
REVIEWS
Usanova A.A., Novikova E.K., Sergutova N.P., Kuzma F., Kunyaeva T.A., Fazlova I.Kh., Guranova N.N., Zhernakova N.I.
Early diagnosis and risk estimation of cardiovascular diseases: Epidemiology, relevance, and comparative analysis of approaches in Russia, in the EU, and in the USA82-89
Nasyryanova S.S., Obukhova L.M.
Ideal marker of renal glomerular filtration rate: Myth or reality?90-99
Karpov Yu.A., Mubarakshina O.A., Tsygankova O.V.,Chesnikova A.I., Rodionova L.V., Timoshchenko E.S., Bykov A.N., Obrezan A.G., Zakharchuk N.V., Patrikeev A.V., Tarlovskaya E.I., Nevzorova V.A., Makarova S.A.
Azilsartan at the start of arterial hypertension therapy: Results of EDARGO-START study100-113
GUIDELINES FOR PRACTITIONERS
Bakulin I.G., Bereznitskaya M.M., Avalueva E.B.
Progressive familial intrahepatic cholestasis: Literature review and clinical case114-124
Devald I.V.
Conservative treatment strategy of degenerative meniscus injury125-130
LECTURE
Prozorova G.G.., Budnevsky A.V., Feigelman S.N.
New opportunities in therapy for severe bronchial asthma131-137
Lagoda O.V., Antonova K.V.
Vascular cognitive impairments: The role of cerebral energy metabolism disorders138-146
Guideline for practitioners
Nevzorova V.A., Bogdanov D.Yu., Kondrashova N.M., Shestopalov E.Yu., Zhidkov E.M., Yakovets R.A., Ilminskaya P.S.
Aspects of remote blood pressure monitoring in follow-up care organization for very high cardiovascular risk patients147-154
Eliashevich S.O., Misharova A.P., Nunyes Araukho D.D., Drapkina O.M.
A fresh angle on nutritional support in chronic kidney disease: PLADO nutritional model155-163
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT
Druk I.V., Safronova S.S., Kanunnikova O.I., Zhamalov L.M.
Influence of ipragliflosin on cardiac electrical activity in patients with type 2 diabetes mellitus and arterial hypertension164-172
Stolyarova V.V., Orlova D.A., Yamashkina E.I., Esina M.V., Skopina Yu.A., Shokina S.V., Al- Katta K.H.K.
Estimation of some myocardial electrical instability indexes in patients with obesity174-180
Babak S.L., Gorbunova M.V., Malyavin A.G.
The role of bradykinin as a pathogenetic target and prospects for pharmacological correction of cough associated with angiotensin-converting enzyme inhibitors: Results of an open-ended prospective observational program181-188
Activities of RNMOT
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (November – December 2025)
189-195
WE REMEMBER
Andrey Georgievich Malyavin (29.07.1958 - 01.12.2025)
196
